0001437749-24-010505.txt : 20240402 0001437749-24-010505.hdr.sgml : 20240402 20240402083048 ACCESSION NUMBER: 0001437749-24-010505 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240401 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO KEY INTERNATIONAL INC CENTRAL INDEX KEY: 0001019034 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 411761861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13463 FILM NUMBER: 24812312 BUSINESS ADDRESS: STREET 1: 101 CRAWFORDS CORNER RD STREET 2: SUITE 4116 CITY: HOLMDEL STATE: NJ ZIP: 07733 BUSINESS PHONE: 7323591100 MAIL ADDRESS: STREET 1: 101 CRAWFORDS CORNER RD STREET 2: SUITE 4116 CITY: HOLMDEL STATE: NJ ZIP: 07733 FORMER COMPANY: FORMER CONFORMED NAME: SAC TECHNOLOGIES INC DATE OF NAME CHANGE: 19961115 8-K 1 bkyi20240401_8k.htm FORM 8-K bkyi20240401_8k.htm
false 0001019034 0001019034 2024-04-01 2024-04-01
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): April 1, 2024
 
BIO-key International, Inc.
(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of incorporation)
1-13463
(Commission File Number)
41-1741861
(I.R.S. Employer Identification No.)
 
101 Crawfords Corner Road,  Suite 4116
Holmdel, NJ 07733
(Address of principal executive offices)
 
(732) 359-1100
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol(s) Name of each exchange on which registered
 Common Stock BKYI Nasdaq Capital market
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 2.02.
Results of Operations and Financial Condition.
 
On April 1, 2024 BIO-key International, Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and year ended December 31, 2023. A copy of the press release issued by the Company on April 1, 2024 is attached as Exhibit 99.
 
The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
 
 
 
Item 9.01.
Financial Statements, Pro Forma Financial Information and Exhibit.
 
(d) Exhibits. The following exhibit is furnished herewith:
   
99.1 Press Release, dated April 1, 2024 issued by the Company.
   
104 Cover Page Interactive Data File (embedded with the Inline XBRL document)
 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  BIO-KEY INTERNATIONAL, INC.  
Date: April 2, 2024      
       
  By: /s/ Cecilia C. Welch  
    Cecilia C. Welch  
    Chief Financial Officer  
 
 

 
EXHIBIT INDEX
 
Exhibit No. Description
   
99.1 Press Release, dated April 1, 2024 issued by the Company.
 
 
EX-99.1 2 ex_648746.htm EXHIBIT 99.1 ex_648746.htm

Exhibit 99.1

 

pic1.jpg

 

Identity and Access Management Software Provider BIO-key Preliminary 2023 Results:

Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10am ET

 

Holmdel, NJ April 1, 2024 BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced preliminary results for its fourth quarter (Q4’23) and year ended December 31, 2023 (2023). The independent audit of BIO-key’s 2023 financial statements has not yet been completed and, therefore, the figures included herein are subject to change. BIO-key will host an investor call tomorrow at 10:00am ET (details below).

 

Preliminary Results Highlights:

2023 revenue rose $2M (29%) to $9.1M

2023 SG&A trimmed by $2.1M (22%)

Net cash used in operating activities was reduced by $2.5M in 2023

Q4’23 & 2023 cost of hardware reflects $2.8M reserve against slow moving inventory for Africa

$1.5M cash payment received in Q1’24 for 2-year extension/expansion of biometric technology license

 

CEO Commentary

BIO-key CEO, Mike DePasquale commented, “BIO-key made solid progress on our path to profitability in 2023, driven by 29% revenue growth and cost cutting initiatives that trimmed SG&A expense by $2.1M, largely in the second half of the year. We look to build on this record in 2024, focusing on top-line growth opportunities balanced with further efforts to reduce costs. We believe our growing global distribution and customer base puts us in a strong position to reach profitability over the next several quarters.

 

“Looking forward, we expect increased deployment of enhanced IAM solutions as enterprises transition to the cloud and respond to a growing array of security incidents that highlight potential cybersecurity vulnerabilities. This trend is further supported by regulatory requirements and increasingly stringent Cyber Insurance underwriting standards that mandate enhanced multi-factor authentication and/or passwordless security solutions that are at the core of our offerings.

 

“As passwordless authentication gains traction, our solutions are well positioned to provide organizations an integrated approach to managing and securing all of their identities with technologies they already use, while also supporting their future needs with a cost-effective platform. We also expect that passkey authentication, which has been embraced by Google, Apple, Amazon and Microsoft, will continue to expand its penetration in 2024. To capitalize on this opportunity, BIO-key will soon launch, Passkey:YOU, a unique passwordless authentication solution that does not require the use of phones or hardware tokens, with planned enhancements expected later in the year.

 

Outlook

“The current climate of broad enterprise adoption of MFA to replace passwords presents opportunities for us to leverage our unique differentiators and exploit gaps in existing IAM approaches. Gaps include challenges of authenticating users that ‘rove’ among workstations and preventing unauthorized account sharing and delegation.

 

 

 

“Today BIO-key has more than 600 customers globally. Our business is predominately SaaS or subscription based, and most of our new business is sold through channel partners. We remain focused on an asset light go-to-market plan that leverages more than 150 Channel Alliance Partners, along with our targeted internal sale team. Together, we believe these channels position BIO-key for meaningful top- and bottom-line improvement in 2024, building on our base of annually recurring services and license fee revenues (ARRs) with a blended gross margin of approximately 65%.

 

“We will also continue to pursue cost reduction initiatives in 2024, to help accelerate our path to positive cash flow and profitability. Our Q4’23 bottom line included a $2.8M non-cash reserve on slow moving hardware inventory purchased for our Africa initiatives. We continue to explore opportunities to convert this inventory into cash. Importantly, during the first quarter of 2024 we enhanced our financial position with the execution of a $1.5M, 2-year license extension for a long-time customer and receipt the full license payment. We also continue to pursue large enterprise opportunities through our direct sales channel. For these and other reasons, we are particularly excited about BIO-key’s outlook for 2024.”

 

Preliminary Financial Results

Please note that the audit of our 2023 financial statements has not been completed by our independent registered public accounting firm as of the date of this press release and are, therefore, subject to change.

 

2023 revenues increased 29% to $9.1M from $7.0M in 2022, driven by increases in license fees (of $1.1M), hardware sales (of $0.5M); and services revenue (of $0.4M). Service revenue benefitted from custom services for new customer installations, Swivel Secure service fees, and conversions from on-premises deployments of PortalGuard to our PortalGuard IDaaS cloud platform. Hardware revenue benefitted from fourth quarter sales to an international defense agency in 2023. Likewise, Q4’23 revenue grew 26% over Q4’22, also driven by the aforementioned hardware sales to an international defense agency.

 

The Company took a $2.8M reserve on inventory due to slow moving inventory purchased for large projects in Nigeria in Q4’23. This reserve was included in cost of hardware, which caused a decline in gross profit to $3.3M in 2023, from $4.6M in 2022 and a decline in gross margin to 36.5% in 2023 from 65.2% in 2022. BIO-key continues to explore opportunities to sell the product, including other markets, to convert inventories to cash.

 

In terms of operating expenses, Selling, general and administrative costs were $7.3M in 2023, representing a 22% decrease from 2022. The decrease included lower sales and marketing expenses, including personnel and related benefits and outside services expenses. Research, development and engineering expenses also declined by $0.9M or 26% to $2.4M, due to reductions in personnel, related benefits and outside services expenses.

 

On a preliminary basis, reflecting higher revenue and lower operating costs, BIO-key significantly trimmed its 2023 net loss 48% to $(6.2M), or $(11.45) per share, from $(12.2M), or $(27.26) per share, in 2022, even after including the $2.8 million reserve on inventory. Likewise, in Q4’23 BIO-key reduced its net loss more than 40% to $(4.1M), or $(5.54) per share, from $(6.7M), or $(14.58) per share in 2023.

 

 

 

Preliminary Balance Sheet

At December 31, 2023, BIO-key had current assets of $5.3M, including $0.5M of cash and cash equivalents, $3.2M of accounts receivable and amounts due from factor, and $1.2M of inventory.

 

Conference Call Details

Date / Time: Tuesday, April 2nd at 10 a.m. ET
Call Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int’l
Live Webcast / Replay: Webcast & Replay Link – Available for 3 months.
Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 6114035

 

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

 

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

 

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

 

Investor Contacts

William Jones, David Collins

Catalyst IR

BKYI@catalyst-ir.com or 212-924-9800

 

 
EX-101.SCH 3 bkyi-20240401.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 bkyi-20240401_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 bkyi-20240401_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 bkyi-20240401_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 pic1.jpg begin 644 pic1.jpg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htm IDEA: XBRL DOCUMENT v3.24.1
Document And Entity Information
Apr. 01, 2024
Document Information [Line Items]  
Entity, Registrant Name BIO-key International, Inc.
Document, Type 8-K
Document, Period End Date Apr. 01, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 1-13463
Entity, Tax Identification Number 41-1741861
Entity, Address, Address Line One 101 Crawfords Corner Road,  Suite 4116
Entity, Address, City or Town Holmdel
Entity, Address, State or Province NJ
Entity, Address, Postal Zip Code 07733
City Area Code 732
Local Phone Number 359-1100
Title of 12(b) Security Common Stock
Trading Symbol BKYI
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001019034
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.bkyi.com/20240401/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports bkyi-20240401.xsd bkyi-20240401_def.xml bkyi-20240401_lab.xml bkyi-20240401_pre.xml bkyi20240401_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bkyi20240401_8k.htm": { "nsprefix": "bkyi", "nsuri": "http://www.bkyi.com/20240401", "dts": { "schema": { "local": [ "bkyi-20240401.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "bkyi-20240401_def.xml" ] }, "labelLink": { "local": [ "bkyi-20240401_lab.xml" ] }, "presentationLink": { "local": [ "bkyi-20240401_pre.xml" ] }, "inline": { "local": [ "bkyi20240401_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.bkyi.com/20240401/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "bkyi20240401_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "bkyi20240401_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.bkyi.com/20240401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001437749-24-010505-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-010505-xbrl.zip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end XML 19 bkyi20240401_8k_htm.xml IDEA: XBRL DOCUMENT 0001019034 2024-04-01 2024-04-01 false 0001019034 8-K 2024-04-01 BIO-key International, Inc. DE 1-13463 41-1741861 101 Crawfords Corner Road,  Suite 4116 Holmdel NJ 07733 732 359-1100 Common Stock BKYI NASDAQ false false false false false